Skip to main content
. 2017 Jun 27;8(40):67592–67604. doi: 10.18632/oncotarget.18749

Figure 2. Effects of cetuximab or SYM004 in induction of apoptosis in a panel of human colorectal cancer cell lines.

Figure 2

(A-B) Cetuximab-sensitive and resistant CRC cells were treated for 48 hours with the 5 μg/ml of cetuximab or SYM004. Apoptosis was evaluated with Annexin V staining, as described in Materials and Methods and the rate of apoptosis was expressed as a percentage of the total cells counted.